T. Nguyen Van, N. De Kimpe / Tetrahedron Letters 45(2004) 3443–3446
3445
OMe
OMe
2 equiv. p-TsOH
O
O
CH3CN, H2O (1:1)
OH
100°C, 3 h
OMe
10 (75%)
OMe
9
3 equiv. CAN
CH3CN, H2O (1:1)
rt, 30 min
O
O
O
p-TsOH (catalyst)
O
O
benzene, 80°C
20 min
OH
O
1 (72%)
2 (91%)
Scheme 2.
6. Kesteleyn, B.; De Kimpe, N.; Van Puyvelde, L. J. Org.
Chem. 1999, 64, 1173–1179.
7. Kesteleyn, B.; De Kimpe, N.; Van Puyvelde, L. Synthesis
1999, 1881–1883.
8. Kesteleyn, B.; De Kimpe, N. J. Org. Chem. 2000, 65, 640–
644.
9. Tuyen Nguyen, V.; Kesteleyn, B.; De Kimpe, N. Tetra-
hedron 2001, 57, 4213–4219.
10. De Kimpe, N.; Kesteleyn, B.; Tuyen Nguyen, V.; Van
Puyvelde, L. 18th International Congress of Heterocyclic
Chemistry, Yokohama, Japan, July 29–August 3, 2001,
p 120.
Psychorubrin 2 was prepared in 91% yield by treatment
of hemiacetal 10 with cerium(IV) ammonium nitrate
(CAN) in aqueous acetonitrile at room temperature for
30 min.6 Finally, pentalongin 1 was obtained in 72%
yield by treatment of psychorubrin 2 with p-toluene-
sulfonic acid in benzene at 80 °C for 20 min.7;12;13 All
attempts to carry out the direct oxidation of compound
9 to pentalongin 1 by using several oxidative reagents
such as CAN, AgO, HNO3 and CrO3 failed. This
problematic oxidation of certain pyranonaphthalene
derivatives was already observed by us6 and others.25
11. Van Puyvelde, L.; Hakizayezu, D.; Brioen, P.; De Kimpe,
N.; De Vroey; C.; Bogaerts, J.; Hakizamungu, E.,
Presented at the International Congress on Natural
Products Research, Halifax, Nova Scotia, Canada, July
31–August 4, 1994.
12. Hayashi, T.; Smith, F. T.; Lee, K.-H. J. Med. Chem. 1987,
30, 2005–2008.
13. Pialat, J.-P.; Hoffmann, P.; Moulis, C.; Fouraste, I.;
Labidalle, S. Nat. Prod. Lett. 1998, 12, 23–30.
14. Okimoto, Y.; Sakaguchi, S.; Ishii, Y. J. Am. Chem. Soc.
2002, 124, 1590–1591.
In conclusion, by using a new synthetic approach, that
is, a RCMstrategy, the naturally occuring antibiotics
pentalogin 1 and psychrubrin 2 were synthesized
in high yield. This protocol now opens a new way
for the synthesis of other pyranonaphthoquinone
antibiotics.
15. (E)-3-(1-Propenyl)-2-vinyloxymethyl-1,4-dimethoxynaph-
1
Acknowledgements
thalene 8. H NMR (CDCl3, 270 MHz): d 1.97 (3H, dd,
J ¼ 6:6 and 1.6 Hz, CH3), 3.82 (3H, s, OMe), 3.86 (3H, s,
OMe), 4.14 (1H, dd, J ¼ 6:9 and 2.3 Hz, CH@CHaHb),
4.40 (1H, dd, J ¼ 6:9 and 2.0 Hz, CH@CHaHb), 4.93 (2H,
s, OCH2), 6.25–6.34 (1H, m, CH3CH@CH), 6.56–6.68
(2H, m, overlap., MeACH@CHA), 7.48–7.54 (2H, m, H-6
and H-7), 8.07–8.13 (2H, m, H-5 and H-8). 13C NM R
(CDCl3, 67 MHz): d 19.7 (Me), 60.6 (OMe), 62.7 (CH2O),
63.7 (OMe), 87.0 (OCH@CH), 122.6 (CH@), 122.7
(CH@), 123.8 (@Cquat), 123.9 (CH@), 126.0 (@Cquat),
126.7 (CH@), 127.4 (CH@), 128.3 (@Cquat), 129.4 (CH@),
132.8 (@Cquat), 150.0 (OACH@CH), 151.4 (@CAOMe),
152.4 (@CAOMe). IR (NaCl): 2916; 2854:1640 (C@C),
1607 (C@C), 1451; 1354:1191, 1061, 1051 cmÀ1. M Sm=z
(%): no Mþ, 257 [(M)vinyl)þ, 20], 242 (20), 241 (100), 210
(14), 149 (10). Anal. Calcd for C18H20O3: C 76.03, H 7.09;
found C 76.12, H 7.20.
The authors are indebted to Johnson and Johnson
(Beerse, Belgium), divison of Janssen Pharmaceutica,
for financial support.
References and notes
1. Thomson, R. H. Naturally Occuring Quinones, 2nd ed.;
Academic: London, 1971; p 282 see also p 597.
2. Wang, W.; Li, T.; Milburn, R.; Yates, J.; Hinnant, E.;
Luzzio, M. J.; Noble, S. A.; Attardo, G. Bioorg. Med.
Chem. Lett. 1998, 8, 1579–1584.
3. Lee, H.; Hong, S. S.; Kim, Y. H. Bioorg. Med. Chem. Lett.
1996, 6, 933–936.
4. Brimble, M. A.; Nairn, M. R.; Prabaharan, H. Tetrahe-
dron 2000, 56, 1937–1992.
5. Naruta, Y.; Maruyama, J. Recent Advances in the
Synthesis of Quinoid Compounds. In The Chemistry of
Quinoid Compounds; Patai, S., Rappoport, Z., Eds.; John
Wiley: New York, 1988; Vol. II, p 241.
16. 5,10-Dimethoxy-1H-naphtho[2,3-c]pyran 9. White pow-
der, mp 138–139 °C, 1H NMR, 13C NMR and MS data
were identical to data reported in the literature.7
17. (a) Clark, J. S.; Kettle, J. G. Tetrahedron Lett. 1997, 38,
123–126; (b) Clark, J. S.; Kettle, J. G. Tetrahedron Lett.
1997, 38, 127–130.